CABACabaletta Bio, Inc.
$1.94-16% 1Y
$1.94
$1.8852 weeks$4.15
Price
-16%1YEnd-of-day closes, not the intraday tick.
RyuScore
Weak, higher than 7% of companiesThe five questions
2 of 5 availableOnly two of the five can be answered for CABA today. The rest need figures this filer has not published. The tabs above still show whatever data does exist.
- Is the business good?not enough filed
- Is it safe?Watch
- Is the price fair?not enough filed
- Is it growing?not enough filed
- What is the market doing?Watch
P/En/a
Market value$316.3M
1 year-16%
5 years-84%
Charts
As reported to the SEC, without any scoring.
The next results filing is expected around Nov 9, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Sep 14, 2026In connection with Cabaletta Bio’s (the “Corporation”) June 2025 underwritten public offering, the Corporation issued 53,090,190 common stock warrants (the “Common Stock Warrants”) that had an exercise price of $2.50 per whole share of its common stock and an expiration date of September 12, 2026 (the “Expiration …Other event · Form 8-K
- Aug 13, 2026Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update.Earnings release · press release
- Jun 11, 2026On June 9, 2026, Cabaletta Bio, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”)Charter/bylaw amendment or fiscal-year change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.